|
Q3 FY2026
As of Jul 4, 2026
|
Q2 FY2026
As of Apr 4, 2026
|
Q1 FY2026
As of Jan 3, 2026
|
Q4 FY2025
As of Oct 4, 2025
|
Q3 FY2025
As of Jun 28, 2025
|
Q2 FY2025
As of Mar 29, 2025
|
Q1 FY2025
As of Dec 28, 2024
|
Q4 FY2024
As of Sep 28, 2024
|
Q3 FY2024
As of Jun 29, 2024
|
Q2 FY2024
As of Mar 30, 2024
|
Q1 FY2024
As of Dec 30, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jul 1, 2023
|
Q2 FY2023
As of Apr 1, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Oct 1, 2022
|
Q3 FY2022
As of Jul 2, 2022
|
Q2 FY2022
As of Apr 2, 2022
|
Q1 FY2022
As of Jan 1, 2022
|
Q4 FY2021
As of Oct 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts and other receivable, net of allowance for doubtful accounts of $ - and $ -, respectively | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating right-of-use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Equity investments | ||||||||||||||||||||
| Investment in debt securities | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Preferred Stock, Shares Authorized (in shares) | ||||||||||||||||||||
| Common Stock, Shares, Outstanding (in shares) | ||||||||||||||||||||
| Common Stock, Shares, Issued (in shares) | ||||||||||||||||||||
| Common Stock, Shares Authorized (in shares) | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Preferred stock, without par value: Authorized 5,000 shares; issued - none | ||||||||||||||||||||
| Common stock, without par value: Authorized 200,000 shares; issued 85,364 and 85,364, respectively; outstanding 52,333 and 51,920 shares, respectively | ||||||||||||||||||||
| Treasury stock, at cost, 33,031 and 33,444 shares, respectively | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| TOTAL SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |
Loading...
